Iovance says clear line of sight to profitability
Iovance Biotherapeutics says record Amtagvi sales underpin a “clear line of sight to profitability” as it prepares for year-end data and trial updates.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.